Jean‐Philippe Metges
About
Jean‐Philippe Metges is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Jean‐Philippe Metges has authored 113 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 51 papers in Pulmonary and Respiratory Medicine and 39 papers in Surgery. Recurrent topics in Jean‐Philippe Metges's work include Gastric Cancer Management and Outcomes (36 papers), Colorectal Cancer Treatments and Studies (32 papers) and Esophageal Cancer Research and Treatment (26 papers). Jean‐Philippe Metges is often cited by papers focused on Gastric Cancer Management and Outcomes (36 papers), Colorectal Cancer Treatments and Studies (32 papers) and Esophageal Cancer Research and Treatment (26 papers). Jean‐Philippe Metges collaborates with scholars based in France, United States and Spain. Jean‐Philippe Metges's co-authors include Dimitris Visvikis, Olivier Pradier, Laurent Corcos, Mathieu Hatt, N. Albarghach, Catherine Cheze Le Rest, Florent Tixier, Manish A. Shah, Antoine Adenis and Éric François and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Jean‐Philippe Metges
102 papers receiving 2.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jean‐Philippe Metges France | 22 | 1.2k | 817 | 719 | 709 | 252 | 113 | 2.2k | ||
| Jeffrey Meyer United States | 23 | 621 0.5× | 790 1.0× | 557 0.8× | 573 0.8× | 227 0.9× | 125 | 2.3k | ||
| Masashi Wakabayashi Japan | 23 | 1.4k 1.2× | 1.9k 2.3× | 515 0.7× | 808 1.1× | 218 0.9× | 136 | 3.2k | ||
| Wen-Fei Li China | 23 | 920 0.8× | 592 0.7× | 405 0.6× | 662 0.9× | 199 0.8× | 63 | 1.9k | ||
| Yanfeng Hu China | 26 | 880 0.8× | 1.5k 1.9× | 589 0.8× | 754 1.1× | 379 1.5× | 103 | 2.5k | ||
| Silvana C. Faria United States | 20 | 634 0.5× | 1.0k 1.3× | 661 0.9× | 599 0.8× | 217 0.9× | 60 | 2.4k | ||
| Paul Sargos France | 26 | 552 0.5× | 1.7k 2.1× | 408 0.6× | 610 0.9× | 211 0.8× | 200 | 2.5k | ||
| Loïc Verlingue France | 14 | 719 0.6× | 463 0.6× | 640 0.9× | 276 0.4× | 242 1.0× | 51 | 1.4k | ||
| Giuseppe Roberto D’Agostino Italy | 30 | 669 0.6× | 1.1k 1.4× | 396 0.6× | 607 0.9× | 286 1.1× | 125 | 2.4k | ||
| Antonio Avallone Italy | 34 | 2.0k 1.7× | 803 1.0× | 1.2k 1.7× | 851 1.2× | 323 1.3× | 195 | 3.6k | ||
| Alice Chen United States | 7 | 1.3k 1.1× | 624 0.8× | 332 0.5× | 241 0.3× | 221 0.9× | 14 | 1.8k |
Countries citing papers authored by Jean‐Philippe Metges
Since
Specialization
Citations
This map shows the geographic impact of Jean‐Philippe Metges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Philippe Metges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Philippe Metges more than expected).
Fields of papers citing papers by Jean‐Philippe Metges
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jean‐Philippe Metges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Philippe Metges. The network helps show where Jean‐Philippe Metges may publish in the future.
Co-authorship network of co-authors of Jean‐Philippe Metges
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Philippe Metges. A scholar is included among the top collaborators of Jean‐Philippe Metges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Philippe Metges. Jean‐Philippe Metges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Metges, Jean‐Philippe, Bogdan Badic, Rosemary L. Sparrow, et al.. (2025). Perioperative red blood cell transfusion following high-risk oncologic surgery for tumor resection: a systematic review and meta-analysis. Transfusion Clinique et Biologique. 33(1). 30–39.
2.
Shitara, Kohei, Yung‐Jue Bang, Lucjan Wyrwicz, et al.. (2024). Neoadjuvant/adjuvant pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: Major pathologic response (mPR) in KEYNOTE-585.. Journal of Clinical Oncology. 42(16_suppl). 4073–4073.
3.
Pant, Shubham, Jia Fan, Do‐Youn Oh, et al.. (2024). Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study.. Journal of Clinical Oncology. 42(16_suppl). 4091–4091.
4.
Neuzillet, Cindy, Olivier Bouché, Christophe Tournigand, et al.. (2023). Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial. Journal of the National Comprehensive Cancer Network. 21(12). 1234–1242.e17.
5.
Bourbonne, Vincent, Ulrike Schick, Olivier Pradier, et al.. (2023). Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?. Cancers. 15(2). 432–432.
6.
Thuillier, Philippe, David Bourhis, J Leclère, et al.. (2023). Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer. Scientific Reports. 13(1). 5789–5789.
7.
Ciardiello, Fortunato, Yung‐Jue Bang, Andrés Cervantes, et al.. (2023). Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first‐line platinum‐based chemotherapy: Phase 2 study results. Cancer Medicine. 12(12). 13145–13154.
8.
Klempner, Samuel J., Keun‐Wook Lee, Kohei Shitara, et al.. (2023). ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical Cancer Research. 29(19). 3882–3891.
9.
Metges, Jean‐Philippe, et al.. (2022). Occupational Exposures and Esophageal Cancer: Prog Study. International Journal of Environmental Research and Public Health. 19(16). 9782–9782.
10.
Hilmi, Marc, Emmanuel Mitry, Anthony Turpin, et al.. (2022). A randomized, non-comparative, phase II study of maintenance OSE2101 vaccine alone or in combination with nivolumab (nivo) or FOLFIRI after induction with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): First interim results of the TEDOPAM GERCOR D17-01 PRODIGE 63 STUDY.. Journal of Clinical Oncology. 40(16_suppl). 4148–4148.
11.
Cousin, Sophie, Coralie Cantarel, Jean‐Philippe Guégan, et al.. (2021). Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial. Clinical Cancer Research. 27(8). 2139–2147.
12.
Klempner, Samuel J., Keun‐Wook Lee, Jean‐Philippe Metges, et al.. (2021). Phase 2 study of zolbetuximab plus mFOLFOX6 in claudin 18.2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ): ILUSTRO cohort 2.. Journal of Clinical Oncology. 39(15_suppl). e16063–e16063.
13.
Bachet, Jean‐Baptiste, Hélène Blons, Pascal Hammel, et al.. (2020). Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma. Clinical Cancer Research. 26(19). 5208–5216.
14.
Metges, Jean‐Philippe, et al.. (2020). Three-Dimensional Culture Systems in Gastric Cancer Research. Cancers. 12(10). 2800–2800.
15.
Metges, Jean‐Philippe, Éric François, Manish A. Shah, et al.. (2019). The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer. Annals of Oncology. 30. iv130–iv130.
16.
Hammel, Pascal, Rossana Berardi, Eric Van Cutsem, et al.. (2019). Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).. Journal of Clinical Oncology. 37(4_suppl). TPS471–TPS471.
17.
Metges, Jean‐Philippe, et al.. (2013). Tolérance du 5-fluorouracile chez des patients atteints d’un déficit en dihydropyrimidine déshydrogénase. Journal de Pharmacie Clinique. 32(3). 154–160.
18.
Metges, Jean‐Philippe, Roger Faroux, Jean-Yves Douillard, et al.. (2013). Efficacy and safety of FOLFIRINOX in patients with pancreatic metastatic cancer.. Journal of Clinical Oncology. 31(4_suppl). 248–248.
19.
Tixier, Florent, Catherine Cheze Le Rest, Mathieu Hatt, et al.. (2011). Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer. Journal of Nuclear Medicine. 52(3). 369–378.
20.
Metges, Jean‐Philippe, et al.. (2006). Traitement d’un carcinome épidermoïde primitif du pancréas par gemcitabine. Gastroentérologie Clinique et Biologique. 30(10). 1217–1220.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jeffrey Meyer Breakdown of academic impact, for papers by Masashi Wakabayashi Breakdown of academic impact, for papers by Wen-Fei Li Breakdown of academic impact, for papers by Yanfeng Hu Breakdown of academic impact, for papers by Silvana C. Faria Breakdown of academic impact, for papers by Paul Sargos Breakdown of academic impact, for papers by Loïc Verlingue Breakdown of academic impact, for papers by Giuseppe Roberto D’Agostino Breakdown of academic impact, for papers by Antonio Avallone Breakdown of academic impact, for papers by Alice Chen